NCT06139770

Brief Summary

The goal of this study is to evaluate the treatment effects of an integrated treatment called Family-based and Metacognitive therapy for patients with Anorexia Nervosa. In addition, we will evaluate if an active follow-up of the patients will reduce the number of relapses, which is common during the 1 year after discharge. Fifty patients aged 12-18 years old and their parents will be invited to participate in this study and all will receive the same treatment but be randomly allocated to different follow-up conditions. The active follow-up includes 3 sessions of Metacognitive therapy and the passive follow-up includes ordinary follow-up, with no booster sessions. The patients will be assessed at baseline, pre-treatment, post-treatment, and at 6 and 12 months follow-up.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
7mo left

Started Nov 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress82%
Nov 2023Dec 2026

First Submitted

Initial submission to the registry

August 24, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

November 1, 2023

Completed
17 days until next milestone

First Posted

Study publicly available on registry

November 18, 2023

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Expected
Last Updated

June 22, 2025

Status Verified

June 1, 2025

Enrollment Period

2.1 years

First QC Date

August 24, 2023

Last Update Submit

June 17, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Body Mass Index

    Body mass index

    18 months

Study Arms (2)

Active follow-up

ACTIVE COMPARATOR

The patients will recieve 3 sessions of MCT

Behavioral: Family based therapy- Metacognitive therapy

Passive follow-up

ACTIVE COMPARATOR

The group receives no sessions during follow-up

Behavioral: Family based therapy- Metacognitive therapy

Interventions

Family based therapy and Metacognitive therapy

Active follow-upPassive follow-up

Eligibility Criteria

Age12 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Primary diagnosis of F 50.0 and F 50.1

You may not qualify if:

  • Psychotic symptoms
  • Severe somatic illness
  • Mental retardation or developmental disorder
  • Bipolar disorder
  • Extreme self-mutilation or acute suicidal risks
  • Does not speak or understand Norwegian

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St.Olavs hospital HF

Trondheim, Trøndelag, 7006, Norway

Location

MeSH Terms

Conditions

Anorexia Nervosa

Condition Hierarchy (Ancestors)

Feeding and Eating DisordersMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The patients will receive the same treatment (FBT/MCT) including their parents, and by post treatment the patients will be randomised to two types of follow-up. One group of the patients will be allocated to active follow-up, receiving 3 booster sessions during the 12 months follow-up, and the second group will be followed-up as usual.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 24, 2023

First Posted

November 18, 2023

Study Start

November 1, 2023

Primary Completion

December 1, 2025

Study Completion (Estimated)

December 1, 2026

Last Updated

June 22, 2025

Record last verified: 2025-06

Locations